Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application

Immune checkpoint inhibitors (ICI) have emerged as a powerful oncologic treatment modality for patients with different solid tumors. Unfortunately, the efficacy of ICI monotherapy in ovarian cancer is limited, and combination therapy provides a new opportunity for immunotherapy in ovarian cancer. DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hongyu, Wang, Wenjie, Qi, Wencai, Jin, Weilin, Xia, Bairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546337/
https://www.ncbi.nlm.nih.gov/pubmed/34712221
http://dx.doi.org/10.3389/fimmu.2021.661115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546337/
https://www.ncbi.nlm.nih.gov/pubmed/34712221
http://dx.doi.org/10.3389/fimmu.2021.661115

Ejemplares similares